Acrivon Therapeutics (NASDAQ:ACRV) CEO Peter Blume-Jensen Sells 14,036 Shares of Stock
MarketBeat
Acrivon Therapeutics, Inc. (NASDAQ:ACRV - Get Free Report) CEO Peter Blume-Jensen sold 14,036 shares of the firm's stock in a transaction dated Tuesday, August 25th. The stock was sold at an average price of $2.21, for a total transaction of $31,019.56. Following the sale, the chief executive officer owned 2,230,052 shares of the company's stock, valued at approximately $4,928,414.92. This represents a 0.63% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards.
NASDAQ:ACRV